Form 10-Q ARVINAS, INC. For: Mar 31

Go back to Form 10-Q ARVINAS, INC. For: Mar 31

Arvinas Inc. (ARVN) PT Lowered to $16 at BTIG

May 2, 2025 5:35 AM EDT

BTIG analyst Jeet Mukherjee lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $16.00 (from $69.00) while maintaining a Buy rating.

The analyst comments "ARVN reported 1Q25 earnings, and together with partner Pfizer (PFE, Not Rated), announced a re-prioritization of vepdegestrant's development... More